American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
American Society of Clinical Oncology, Alexandria, VA 22314, USA.
Eric P
EP
Winer
Clifford
C
Hudis
Harold J
HJ
Burstein
John
J
Bryant
Rowan T
RT
Chlebowski
James N
JN
Ingle
Stephen B
SB
Edge
Eleftherios P
EP
Mamounas
Richard
R
Gelber
Julie
J
Gralow
Lori J
LJ
Goldstein
Kathleen I
KI
Pritchard
Susan
S
Braun
Melody A
MA
Cobleigh
Amy S
AS
Langer
Judy
J
Perotti
Trevor J
TJ
Powles
Timothy J
TJ
Whelan
George P
GP
Browman
D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016134:Organizational Policy; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012955:Societies, Medical; D013534:Survival
D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors